{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:08:52Z","timestamp":1790114932390,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jpba.2026.117677","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T22:06:10Z","timestamp":1785103570000},"page":"117677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and validation of reversed phase\u2013high-performance liquid chromatography method for simultaneous quantification of temozolomide and alpha-lipoic acid in bulk and lipidic nanovesicles"],"prefix":"10.1016","volume":"281","author":[{"given":"Sajidul","family":"Hoque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3368-4467","authenticated-orcid":false,"given":"Vinod L.","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117677_bib1","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1080\/10717544.2016.1189465","article-title":"Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?","volume":"23","author":"Qu","year":"2016","journal-title":"Drug. Deliv."},{"key":"10.1016\/j.jpba.2026.117677_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115174","article-title":"Strategies increasing the effectiveness of temozolomide at various levels of anti-GBL therapy","volume":"165","author":"Krajcer","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jpba.2026.117677_bib3","article-title":"Unleashing potential of methotrexate-amino acid methyl ester-loaded lipidic nanocapsules as magic bullets against resistant breast cancer","volume":"104","author":"Shinde","year":"2025","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"10.1016\/j.jpba.2026.117677_bib4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1515\/tsd-2024-2650","article-title":"Exploring fatty acid-amino acid conjugate for the development of self-assembling, pH-sensitive vesicles for targeted anticancer drug delivery","volume":"62","author":"Bhatia","year":"2025","journal-title":"Tenside Surfactants Deterg."},{"key":"10.1016\/j.jpba.2026.117677_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1039\/D5PM00025D","article-title":"Artesunate-loaded bilosomes with enhanced oral bioavailability: in silico and in vitro study against Leishmania donovani promastigotes and in vivo pharmacokinetic assessment in rats","volume":"2","author":"Wankhede","year":"2025","journal-title":"RSC Pharm."},{"key":"10.1016\/j.jpba.2026.117677_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jpba.2018.12.020","article-title":"Development of stability-indicating HPLC method and accelerated stability studies for osmotic and pulsatile tablet formulations of Clopidogrel Bisulfate","volume":"165","author":"Deshmukh","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117677_bib7","first-page":"347","article-title":"A. Kasabe, A.S. Kulkarni, V.L. Gaikwad, Bioanalytical method development and validation for estimation of formulated sustained release tablet of Nateglinide in Rabbit plasma","volume":"11","year":"2019","journal-title":"Int. J. Pharm. Res."},{"key":"10.1016\/j.jpba.2026.117677_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/22297928.2023.2217176","article-title":"Investigation of a quantitative bioanalytical HPLC method for the assessment of famotidine in pre-clinical samples: Application for pharmacokinetic studies","volume":"13","author":"Bharati","year":"2023","journal-title":"Anal. Chem. Lett."},{"key":"10.1016\/j.jpba.2026.117677_bib9","article-title":"Investigation of a biopolymer-based pH-responsive and sustained release raft-gel-forming tablet of famotidine: In-vitro, ex-vivo, bioavailability and anti-ulcer evaluation in New Zealand albino rabbit","volume":"86","author":"Bharati","year":"2023","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"10.1016\/j.jpba.2026.117677_bib10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/22297928.2023.2263012","article-title":"Bioanalytical method development and validation for determination of efonidipine hydrochloride ethanolate in rat plasma by high-performance liquid chromatography: Applications for pharmacokinetic study","volume":"13","author":"Bharati","year":"2023","journal-title":"Anal. Chem. Lett."},{"key":"10.1016\/j.jpba.2026.117677_bib11","author":"Ryan","year":"2023","journal-title":"FDA Approv. New. Update Indic. temozolomide Anaplastic Astro"},{"key":"10.1016\/j.jpba.2026.117677_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/1570159X18666200626204005","article-title":"Temozolomide: An updated overview of resistance mechanisms, nanotechnology advances and clinical applications","volume":"19","author":"Ortiz","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpba.2026.117677_bib13","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.3390\/molecules27113507","article-title":"Temozolomide efficacy and metabolism: The implicit relevance of nanoscale delivery systems","volume":"27","author":"Petrenko","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2026.117677_bib14","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/15384047.2019.1599662","article-title":"Glioblastoma vs temozolomide: can the red queen race be won?","volume":"20","author":"Arora","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.jpba.2026.117677_bib15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/10826076.2018.1511803","article-title":"A simplified and sensitive validated RP-HPLC method for determination of temozolomide in rat plasma and its application to a pharmacokinetic study","volume":"41","author":"Khosa","year":"2018","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2026.117677_bib16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.bbagen.2009.07.026","article-title":"Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential","volume":"1790","author":"Shay","year":"2009","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"key":"10.1016\/j.jpba.2026.117677_bib17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/biom9080356","article-title":"Insights on the use of \u03b1-lipoic acid for therapeutic purposes","volume":"9","author":"Salehi","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpba.2026.117677_bib18","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s00204-014-1434-0","article-title":"Lipoic acid induces p53-independent cell death in colorectal cancer cells and potentiates the cytotoxicity of 5-fluorouracil","volume":"89","author":"D\u00f6rsam","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jpba.2026.117677_bib19","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3892\/ijo.2016.3624","article-title":"\u03b1-Lipoic acid sensitizes lung cancer cells to chemotherapeutic agents and anoikis via integrin \u03b21\/\u03b23 downregulation","volume":"49","author":"Puchsaka","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jpba.2026.117677_bib20","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1021\/acs.biomac.8b01394","article-title":"PEGylated poly(\u03b1-lipoic acid) loaded with doxorubicin as a pH and reduction dual responsive nanomedicine for breast cancer therapy","volume":"19","author":"Yang","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jpba.2026.117677_bib21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/carcin\/bgv070","article-title":"Lipoic acid inhibits the DNA repair protein O 6 -methylguanine-DNA methyltransferase (MGMT) and triggers its depletion in colorectal cancer cells with concomitant autophagy induction","volume":"36","author":"G\u00f6der","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jpba.2026.117677_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbrc.2017.10.030","article-title":"\u03b1-Lipoic acid inhibits human lung cancer cell proliferation through Grb2-mediated EGFR downregulation","volume":"494","author":"Yang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpba.2026.117677_bib23","first-page":"332","article-title":"Mitochondrial dynamics, ROS, and cell signaling: A blended overview","volume":"11","author":"Brillo","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jpba.2026.117677_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114617","article-title":"Garcinone E triggers apoptosis and cell cycle arrest in human colorectal cancer cells by mediating a reactive oxygen species\u2013dependent JNK signaling pathway","volume":"162","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jpba.2026.117677_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s43450-023-00370-1","article-title":"Molecular and therapeutic insights of alpha-lipoic acid as a potential molecule for disease prevention","volume":"33","author":"Tripathi","year":"2023","journal-title":"Rev. Bras. Farmacogn."},{"key":"10.1016\/j.jpba.2026.117677_bib26","series-title":"ACS","year":"2019"},{"key":"10.1016\/j.jpba.2026.117677_bib27","article-title":"Lipoic acid-containing composition","author":"Kuwata","year":"2007","journal-title":"JP5217232B2"},{"key":"10.1016\/j.jpba.2026.117677_bib28","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3390\/molecules27041437","article-title":"Thermodynamic solubility profile of temozolomide in different commonly used pharmaceutical solvents","volume":"27","author":"Ahad","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2026.117677_bib29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/chromsci\/bmy064","article-title":"A rapid and precise liquid chromatographic method for simultaneous determination of alpha lipoic acid and docetaxel in lipid-based nanoformulations","volume":"56","author":"Kothari","year":"2018","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2026.117677_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/978-1-4939-1441-8_25","article-title":"Simultaneous determination of the endogenous free \u03b1-lipoic acid and dihydrolipoic acid in human plasma and erythrocytes by RP-HPLC coupled with electrochemical detector","volume":"1208","author":"Khan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jpba.2026.117677_bib31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jchromb.2007.04.003","article-title":"Simultaneous determination of \u03b1-lipoic acid and its reduced form by high-performance liquid chromatography with fluorescence detection","volume":"854","author":"Satoh","year":"2007","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jpba.2026.117677_bib32","first-page":"855","article-title":"New metabolic pathways of \u03b1-lipoic acid","volume":"29","author":"Schupke","year":"2001","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.jpba.2026.117677_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1573412917999201211204108","article-title":"A quantitative LC-MS\/MS method for the simultaneous determination of the presence of R-\u03b1-lipoic acid and S-\u03b1-lipoic acid after protein precipitation in rat plasma and its application in a toxicokinetic study","volume":"18","author":"Zhou","year":"2022","journal-title":"Curr. Pharm. Anal."},{"key":"10.1016\/j.jpba.2026.117677_bib34","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.4155\/bio.15.95","article-title":"Determination of lipoic acid in biological samples","volume":"7","author":"Borowczyk","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2026.117677_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/00498250410001685737","article-title":"Disposition and pharmacokinetics of temozolomide in rat","volume":"34","author":"Reyderman","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jpba.2026.117677_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jscs.2015.01.008","article-title":"Kinetics, mechanistic and synergistic studies of Alpha lipoic acid with hydrogen peroxide","volume":"21","author":"Muhammad","year":"2017","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.jpba.2026.117677_bib37","first-page":"271","article-title":"Development and full validation of a stability-indicating HPLC method for the determination of the anticancer drug temozolomide in pharmaceutical form","volume":"15","author":"Kap\u00e7ak","year":"2018","journal-title":"Turk. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2026.117677_bib38","author":"ICH","year":"2005","journal-title":"Valid. Anal. Proced. Text. Methodol. Q2(R1)"},{"key":"10.1016\/j.jpba.2026.117677_bib39","unstructured":"ICH, Validation of analytical procedures Q2(R2), (2023). https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q2(R2)_Guideline_2023_1130.pdf (accessed June 19, 2026)."},{"key":"10.1016\/j.jpba.2026.117677_bib40","unstructured":"ICH, Analytical procedure development Q14, (2022). https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q14_Document_Step2_Guideline_2022_0324.pdf (accessed June 19, 2026)."},{"key":"10.1016\/j.jpba.2026.117677_bib41","first-page":"38","article-title":"Getting the peaks perfect: System suitability for HPLC, ACS Today\u2019s","volume":"10","author":"Dong","year":"2001","journal-title":"Chem. Work."},{"key":"10.1016\/j.jpba.2026.117677_bib42","unstructured":"FDA, Q2 (R1) validation of analytical procedures: text and methodology (guidance for industry), (2005). https:\/\/www.fda.gov\/media\/152208\/download (accessed January 12, 2023)."},{"key":"10.1016\/j.jpba.2026.117677_bib43","first-page":"314","article-title":"Step-by-step analytical methods validation and protocol in the quality system compliance industry","volume":"10","author":"Shabir","year":"2004","journal-title":"J. Valid. Technol."},{"key":"10.1016\/j.jpba.2026.117677_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2229-4708.81088","article-title":"Stress degradation studies and development of a validated stability-indicating-assay-method for determination of diacerein in presence of degradation products","volume":"2","author":"Hamrapurkar","year":"2011","journal-title":"Pharm. Methods"},{"key":"10.1016\/j.jpba.2026.117677_bib45","first-page":"129","article-title":"Stability testing of pharmaceutical products","volume":"2","author":"Bajaj","year":"2012","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.jpba.2026.117677_bib46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/pharmaceutics14030543","article-title":"Methods of liposomes preparation: Formation and control factors of versatile nanocarriers for biomedical and nanomedicine application","volume":"14","author":"Lombardo","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpba.2026.117677_bib47","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10611869509015959","article-title":"The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage","volume":"3","author":"Heeremans","year":"1995","journal-title":"J. Drug. Target."},{"key":"10.1016\/j.jpba.2026.117677_bib48","first-page":"402","article-title":"Design of experiment based validated stability indicating RP-HPLC method of temozolomide in bulk and pharmaceutical dosage forms","volume":"5","author":"Khan","year":"2016","journal-title":"Beni. Suef. Univ. J. Basic. Appl. Sci."},{"key":"10.1016\/j.jpba.2026.117677_bib49","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1081\/JLC-200032656","article-title":"Validated method for determination of \u03b1-lipoic acid in dietary supplement tablets by reversed phase liquid chromatography","volume":"27","author":"Aboul-Enein","year":"2004","journal-title":"J. Liq. Chromatogr. Relat. Technol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526003456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526003456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:47:23Z","timestamp":1790113643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526003456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":49,"alternative-id":["S0731708526003456"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117677","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of reversed phase\u2013high-performance liquid chromatography method for simultaneous quantification of temozolomide and alpha-lipoic acid in bulk and lipidic nanovesicles","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117677"}}